# [United States/medicaldaily.com] FDA Approves the First Eye - Specific Bevacizumab for Wet Macular Degeneration After Two Decades of Off - Label Use — retained record

> Retained gdelt record from gdelt:amd.

Canonical: https://highsignal.app/data/records/9908b0cf83ce7843

[← sources](https://highsignal.app/data)


source: [gdelt](https://highsignal.app/data/gdelt) (gdelt:amd)  published 2026-08-04 03:45 ingested 2026-08-04 08:49

[Advanced Micro Devices Inc](https://highsignal.app/entities/AMD)[original source ↗](https://www.medicaldaily.com/fda-approves-lytenava-ophthalmic-bevacizumab-wet-amd-476794)

## retained text

No document body was retained for this record — only its metadata was stored.

document fetched 2026-08-04 08:49 · canonical https://medicaldaily.com/fda-approves-lytenava-ophthalmic-bevacizumab-wet-amd-476794
